Insilicogen and German QuiaGen to Establish and Operate 'Domestic Bio Data Center'
Bioinformatics specialist company Insilicogen Inc. announced on the 11th that it will jointly install and operate a domestic data center with global biotechnology company QIAGEN. QIAGEN is a German bio company that supplies DNA and RNA extraction kits and gene analysis software worldwide.
According to Insilicogen, QIAGEN's domestic data center installation will be the third in the world, following Denmark and the United States. The 'QCII' data center installed in Korea is a web-based software that curates large-scale bioinformatics databases to facilitate access to the field of precision medicine.
QCII is the first NGS interpretation platform to obtain approval under the European In Vitro Diagnostic Medical Device Regulation (CE-IVDR). It supports personalized treatment by clinically interpreting gene variants analyzed from NGS (Next-Generation Sequencing) data.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
An Insilicogen official explained, "QIAGEN has established the QCII data center domestically to enable clinical interpretation of NGS variant data in Korea while complying with domestic medical and data-related laws."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.